Clinical Trial Results TV
November 9, 2005: The Usefulness of Registries to the Field of Interventional Cardiology
This video is sponsored by the Duke Clinical Medical Series.

Topics include:
* The Usefulness of Registries...
* What Interventional Cardiology...
* Major Adverse Cardiac...
* Relationship of MACE and ST
* Limitations of Registries
* Impact of FU Angiography
* Conclusions

The moderator, Peter Berger, MD, has indicated that he receives research/grant support
from Aventis, Conor, Guilford, Lumen, and Velocimed. Dr. Berger is also a member of an
advisory board for Genentech and Cordis/Johnson & Johnson; he has spoken at scientific
symposia for Aventis, Bristol-Myers Squibb, Genentech, and Guilford. Dr. Berger also
serves as Medical Director and has equity with Lumen, Inc.

The guest faculty, Dr. Philip Urban, has indicated that he is a consultant for Cordis,
Terumo, and Boston Scientific.

The Usefulness of Registries to the Field of Interventional Cardiology

Please select your viewing options:

Windows Media: 56k 100k
RealPlayer: 56k 100k
Number Viewing:
Need a media player? Please choose one of the free downloads below:
Get Windows Media PlayerDownload RealPlayer

Video Statistics
0 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 0 total votes.

These statistics are updated nightly. The last update ran on
11-19-2018 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted